Difference between revisions of "User:Shawndouglas/sandbox/sublevel34"
Shawndouglas (talk | contribs) |
Shawndouglas (talk | contribs) |
||
Line 271: | Line 271: | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Phone: [http://dhhs.ne.gov/Pages/Disease-Reporting.aspx Based on county] | | style="background-color:white; padding-left:10px; padding-right:10px;"|Phone: [http://dhhs.ne.gov/Pages/Disease-Reporting.aspx Based on county] | ||
| style="background-color:white; padding-left:10px; padding-right:10px;"|The Nebraska Department of Health and Human Services provides little in the way of specific guidance for reporting COVID-19. They simply [http://dhhs.ne.gov/han%20Documents/UPDATE03132020.pdf state]: "Any patient (+) for COVID-19 virus should be immediately reported to local/state public health office." They define "immediate notification" as "required to call by telephone to a live public health surveillance official within 24 hours of detection." This apparently includes providers currently on ELR. Labs and healthcare providers should verify if any additional reporting (fax, ELR) is required. | | style="background-color:white; padding-left:10px; padding-right:10px;"|The Nebraska Department of Health and Human Services provides little in the way of specific guidance for reporting COVID-19. They simply [http://dhhs.ne.gov/han%20Documents/UPDATE03132020.pdf state]: "Any patient (+) for COVID-19 virus should be immediately reported to local/state public health office." They define "immediate notification" as "required to call by telephone to a live public health surveillance official within 24 hours of detection." This apparently includes providers currently on ELR. Labs and healthcare providers should verify if any additional reporting (fax, ELR) is required. | ||
|- | |||
|- | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|[http://dpbh.nv.gov/Programs/OPHIE/Public_Health_Informatics_and_Epidemiology_-_Home/ Nevada] | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|N | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Y | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|[http://dpbh.nv.gov/Programs/OPHIE/Docs/Updated_Morbidity_Form_-_BP_4_2016/ Confidential Disease Reporting Form] | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Contact: Local health department list in reporting form | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Nevada DHHS guidance [https://nvhealthresponse.nv.gov/wp-content/uploads/2020/04/COVID19_Testing_Technical-Bulletin_4.20.20_FINAL.pdf states] health care providers, medical facilities, and laboratories should immediately notify the head of infection control or laboratory director at their facility AND "their local/state health department in the event of a probable or confirmed case of COVID-19." Its guidance appears to suggest a phone call for such notification. According to the state's [http://dpbh.nv.gov/Programs/OPHIE/Docs/Updated_Morbidity_Form_-_BP_4_2016/ disease reporting form], this phone call should be done in addition to faxing a report. "All cases, suspect cases, and carriers | |||
must be reported within 24 hours." It's not clear if ELR is being accepted for COVID-19 reporting. | |||
|- | |||
|- | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|[https://www.dhhs.nh.gov/dphs/cdcs/forms.htm New Hampshire] | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|N | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Y | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|[https://www.dhhs.nh.gov/dphs/cdcs/covid19/covid19-reporting-form.pdf COVID-19 Case Report Form] | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Phone: (603) 271-4496<br /> <br />Fax: (603) 271-0545 | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Health care providers and laboratories should immediately report suspect and confirmed cases of COVID-19 to the New Hampshire Department of Health and Human Services. It seems likely the DPHHS prefers both a phone call and a faxed report, though it's not explicitly stated. The case should likely be "reported within 24 hours of | |||
diagnosis or suspicion of diagnosis." The NHDHHS disease reporting web page makes no mention of ELR. | |||
|- | |||
|- | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|New Jersey | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Y | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|N (?) | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|No standardized COVID-19 reporting form | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|ELR: [https://cdrs.doh.state.nj.us/cdrss/login/loginPage See quick-start guide]<br /> <br />[https://www.nj.gov/health/cd/reporting/index.shtml Local health departments] | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|"[T]he New Jersey Domestic Security Preparedness Task Force [https://nj.gov/governor/news/news/562020/approved/20200323c.shtml hereby directs] that commercial laboratories operating in New Jersey report all COVID-19 test results to the New Jersey Department of Health beginning March 23, 2020. The results of all COVID-19 tests performed before this date shall be included in the initial report. Subsequently, results shall be sent daily, and included results not previously reported. Information shall be transmitted no later than 8:00 p.m. each day through the Department of Health’s CDRSS platform. Specific data reported shall include positive, negative, and inconclusive test results. This directive shall supplement, not supplant, any other existing reporting requirements." From that statement, it's not clear if laboratories should also be immediately phoning their results to the health department in addition to ELR over CDRSS. | |||
|- | |||
|- | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|[https://nmhealth.org/about/erd/ideb/ids/ New Mexico] | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|N | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Y (?) | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|[https://nmhealth.org/publication/view/form/3288/ Notifiable Condition Report Form] | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Phone: (505) 827-0006<br /> <br />Fax: (505) 827-0013 | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|The New Mexico Department of Health doesn't appear to have published any information about specific COVID-19 reporting requirements. The DoH is [https://nmhealth.org/publication/view/policy/372/ presumably] treating "confirmed or suspected" COVID-19 cases as an immediately reportable event that "require immediate reporting by telephone to Epidemiology and Response Division." It's not clear if a faxed report is also required. The DoH disease reporting web page makes no mention of ELR. | |||
|- | |||
|- | |||
|- | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|[https://www.health.ny.gov/professionals/diseases/reporting/communicable/ New York] | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Y | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|N | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|[http://www.health.ny.gov/forms/doh-389.pdf Confidential Case Report - DOH-389]<br /> <br />[https://www1.nyc.gov/assets/doh/downloads/pdf/hcp/urf-0803.pdf Universal Reporting Form - PD-16] | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|Contact: [https://www.nysacho.org/directory/ Local health departments]<br /> <br />ECLRS: eclrs@health.ny.gov | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|The New York Department of Health [https://coronavirus.health.ny.gov/system/files/documents/2020/04/doh_covid19_privatepracticesamplingsites_041920.pdf states]: "Positive results must be immediately reported to the local Department of Health by the laboratory performing the test, per established guidance, and all test results should be reported by the laboratories into New York State Department of Health’s Electronic Clinical Laboratory Reporting System (ECLRS) four times a day." The established guidance appears to be found in the state's [https://health.ny.gov/forms/instructions/doh-389_instructions.pdf updated reporting instructions], which now includes COVID-19 as a disease that "should be reported immediately to local health departments by phone followed by submission of the confidential case report form (DOH-389). In NYC use case report form PD-16." This means "within 24 hours of diagnosis." The instructions indicate case reports should be mailed. Both health care facilities and laboratories should report. | |||
|- | |||
|- | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"|North Carolina | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | |||
| style="background-color:white; padding-left:10px; padding-right:10px;"| | |||
|- | |- | ||
Revision as of 18:52, 23 April 2020
3. Workflow and information management for COVID-19 (and other pandemics)
3.1 Laboratory informatics and workflow management
3.2 Laboratory informatics and reporting requirements
Epidemiology can broadly be split into two categories: descriptive epidemiology and analytical epidemiology. Descriptive epidemiology involves studies and other activites that deal with geographical comparisons and temporal trend descriptions of disease. As such, the collection and use of quality incidence data is vital to developing hypotheses.[1] Analytical epidemiology allows for the testing of those hypotheses using both experimental and obsevational studies, as well as control groups. Similarly, the collection and use of quality experimental and observational data is vital for proving or disproving hypotheses.[2] In both cases, proper reporting of data is critical to the success of epidemiologists' response to outbreaks and pandemics, as well as the credibility of their research.[3][4]
The proper reporting of COVID-19 case data is no exception. In the United States, the CDC has taken a standardized approach to collecting reports on "individuals with at least one respiratory specimen that tested positive for the virus that causes COVID-19."[5] Their COVID-19 Case Report Form is designed to collect a wide variety of information about a COVID-19 case, including patient demographics, epidemiological characteristics, exposure and contact history, and clinical diagnosis and treatment procedures. Currently, the CDC is asking local and state health departments to submit case reports, and asking healthcare providers to contact those health departments when "concerned that a patient may have COVID-19." The CDC has also slimmed its reporting requirements, limiting reporting of "persons under investigation" to areas where testing must be forwarded to the CDC due to insufficient capacity to test locally.[5] Electronic reporting using the CDC's system is preferred, but they have a protocol for those areas unable to submit electronically. Canada has similar reporting expectations, with their own case report form and electronic data submission process through the Public Health Agency of Canada.[6] And in the European Union, member countries and the U.K. are asked to report through the Early Warning and Response System.[7]
Somewhat related are any internal reporting requirements, particularly for test reporting in labs and medical facilities. The International Statistical Classification of Diseases and Related Health Problems (ICD) is a system of diagnostic codes for classifying diseases, including nuanced classifications of a wide variety of signs, symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or disease. Their ICD-10-CM code set has been modified to include lab testing codes for COVID-19, as has the Current Procedural Terminology (CPT) code set. Green and Bradley provide insight into these additions[8], as does the American Academy of Pediatrics.[9]
Laboratories analyzing specimens for SARS-CoV-2 therefore must be equipped to not only handle analytical testing and test orders using the new test codes, but they also must be able to quickly and accurately transfer vital case information to the appropriate health authority.
|
3.3 Additional benefits of laboratory informatics in disease testing and public health
In a 2013 research paper published in the journal BMJ Quality & Safety, El-Kareh et al. analyzed and described the state of diagnostic health information technology (HIT). They noted that without the aid of HIT, clinicians are more error-prone, leaving them "vulnerable to fallible human memory, variable disease presentation, clinical processes plagued by communication lapses, and a series of well-documented ‘heuristics,’ biases, and disease-specific pitfalls."[10] Appropriate, well-designed HIT systems are capable of helping clinicians and laboratorians by providing more timely access to information, improved communication, better clinical reasoning and decision making, and improved workflows, as well as a reduction in diagnostic errors, and, as a result, improved patient safety and health outcomes.[11]
From a public health perspective, the application of informatics to disease surveillance, reporting, and health promotion is also vital. Winters-Miner et al. note in particular the value of using informatics tools and methods to implement predictive analytics and data mining into public health. They use disease prevention and biosurveillance as major examples. We could, for example "analyze large populations of people to quantify risks related to public health, and help physicians to develop intervention programs for those patients at highest risk of some ailment or medical condition."[12] Additionally, through the use of syndromic surveillance systems (tools aiding in the detection of indicators leading up to disease diagnosis for individuals and populations[13]), they suggest that outbreaks can be better detected at local and national levels, and public health measures can be better implemented, increasing public awareness and hindering the spread of disease.[12]
https://www.nature.com/articles/s41746-019-0110-4 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204239/ https://www.nap.edu/read/21794/chapter/7#241 https://www.mlo-online.com/home/article/13017228/poct-made-easier-with-informatics
3.3.1 Bioinformatics
References
- ↑ Naito, M. (2014). "Utilization and application of public health data in descriptive epidemiology". Journal of Epidemiology 24 (6): 435–6. doi:10.2188/jea.je20140182. PMC PMC4213216. PMID 25327184. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213216.
- ↑ Centers for Disease Control and Prevention (2012) (PDF). Principles of Epidemiology in Public Health Practice (3rd ed.). Centers for Disease Control and Prevention. https://www.cdc.gov/csels/dsepd/ss1978/SS1978.pdf. Retrieved 11 April 2020.
- ↑ Hamilton, J.J.; Hopkins, R.S. (2019). "Chapter 5: Using Technologies for Data Collection and Management". In Rasmussen, S.A.; Goodman, R.A.. The CDC Field Epidemiology Manual (4th ed.). Oxford University Press. pp. 71–104. ISBN 9780190933692.
- ↑ von Elm, E.; Altman, D.G.; Egger, M. et al. (2007). "The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies". PLoS Medicine 4 (10): e296. doi:10.1371/journal.pmed.0040296. PMC PMC2020495. PMID 17941714. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2020495.
- ↑ 5.0 5.1 Centers for Disease Control and Prevention (21 March 2020). "Information for Health Departments on Reporting Cases of COVID-19". Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/php/reporting-pui.html. Retrieved 21 March 2020.
- ↑ Government of Canada (10 February 2020). "Interim national surveillance guidelines for human infection with Coronavirus disease (COVID-19)". Government of Canada. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals/interim-guidance-surveillance-human-infection.html. Retrieved 11 April 2020.
- ↑ European Centre for Disease Prevention and Control (2 March 2020). "Case definition and European surveillance for COVID-19, as of 2 March 2020". COVID-19 Portal. European Centre for Disease Prevention and Control. https://www.ecdc.europa.eu/en/case-definition-and-european-surveillance-human-infection-novel-coronavirus-2019-ncov. Retrieved 11 April 2020.
- ↑ Green, C.; Bradley, V. (1 April 2020). "Coding guidance for new ICD-10-CM and lab testing codes for COVID-19". MGMA Stat. https://www.mgma.com/data/data-stories/coding-guidance-for-new-icd-10-cm-and-lab-testing. Retrieved 11 April 2020.
- ↑ AAP Division of Health Care Finance (12 March 2020). "How to use ICD-10-CM, new lab testing codes for COVID-19". American Academy of Pediatrics. https://www.aappublications.org/news/2020/03/12/coding031220. Retrieved 11 April 2020.
- ↑ El-Kareh, R.; Hasan, O.; Schiff, G.D. (2013). "Use of health information technology to reduce diagnostic errors". BMJ Quality & Safety 22 (Suppl. 2): ii40–ii51. doi:10.1136/bmjqs-2013-001884. PMC PMC3786650. PMID 23852973. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786650.
- ↑ National Academies of Sciences, Engineering, and Medicine (2015). "Chapter 5: Technology and Tools in the Diagnostic Process". Improving Diagnosis in Health Care. The National Academies Press. pp. 217–62. doi:10.17226/21794. ISBN 9780309377720. https://www.nap.edu/read/21794/chapter/7.
- ↑ 12.0 12.1 Winters-Miner, L.A.; Bolding, P.S.; Hilbe, J.M. et al. (2015). "Chapter 3: Biomedical Informatics". Practical Predictive Analytics and Decisioning Systems for Medicine. Academic Press. pp. 42–59. doi:10.1016/B978-0-12-411643-6.00003-X. ISBN 9780124116436.
- ↑ Mandl, K.D.; Overhage, J.M.; Wagner, M.M. et al. (2004). "Implementing syndromic surveillance: A practical guide informed by the early experience". JAMIA 11 (2): 141–50. doi:10.1197/jamia.M1356. PMC PMC353021. PMID 14633933. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC353021.